SCHEMBL21035667

SCHEMBL21035667

CC(C)(C)OC(=O)NC1CC2CCC(C1)N2C(=O)[C@@H]1C[C@@H](Oc2ccc(Cl)cc2)CCN1S(=O)(=O)c1ccc2cc(OC3CCCC3)ccc2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB1 P05556 3/20 0.39
ITGA4 P13612 3/20 0.39
HTR1A P08908 2/20 0.38
HTR7 P34969 2/20 0.38
HTR5A P47898 2/20 0.38
HTR1D P28221 1/20 0.38
HTR1B P28222 1/20 0.38
HTR2A P28223 1/20 0.38
HTR2C P28335 1/20 0.38
ADRA1A P35348 1/20 0.38
HTR2B P41595 1/20 0.38
HTR6 P50406 1/20 0.38
HTR4 Q13639 1/20 0.38
KCNQ1 P51787 1/20 0.36
HRH1 P35367 2/20 0.36
CCR3 P51677 2/20 0.36
HCRTR1 O43613 2/20 0.36
HCRTR2 O43614 2/20 0.36
GPR119 Q8TDV5 1/20 0.36
KCNH2 Q12809 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21035008 0.99 ITGB1 (0.38) ITGB1ITGA4HTR1AHTR7HTR5A
SCHEMBL21035131 0.99 ITGB1 (0.38) ITGB1ITGA4HTR1AHTR7HTR5A
SCHEMBL21035316 0.94 MMP9 (0.36) ITGB1ITGA4HTR1AHTR7HTR5A
SCHEMBL21035404 0.94 MMP9 (0.36) ITGB1ITGA4HTR1AHTR7HTR5A
SCHEMBL21036266 0.91 ITGB1 (0.40) ITGB1ITGA4HTR1AHTR7HTR5A
SCHEMBL21035112 0.90 ITGB1 (0.38) ITGB1ITGA4HTR1AHTR7HTR5A
SCHEMBL21035531 0.90 ITGB1 (0.38) ITGB1ITGA4HTR1AHTR7HTR5A
SCHEMBL21036257 0.89 GHSR (0.38) ITGB1ITGA4HTR1AHTR7HTR5A
SCHEMBL21034998 0.89 GHSR (0.38) ITGB1ITGA4HTR1AHTR7HTR5A
SCHEMBL21036286 0.89 GHSR (0.38) ITGB1ITGA4HTR1AHTR7HTR5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019104011-A1 CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE BIOMARIN PHARMACEUTICAL INC. (US) 2019-05-31 WO disclosed